EP 4072670 B1 20231122 - QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS
Title (en)
QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS
Title (de)
CHINAZOLINDERIVATE ALS LPA-REZEPTOR-2-INHIBITOREN
Title (fr)
DÉRIVÉS DE QUINAZOLINE UTILISÉS EN TANT QU'INHIBITEURS DU RÉCEPTEUR 2 DE LPA
Publication
Application
Priority
- EP 19215719 A 20191212
- EP 2020085460 W 20201210
Abstract (en)
[origin: WO2021116260A1] The present invention relates to a compounds of general formula (I) inhibiting lysophosphatidic acid receptor 2 (LPA2), particularly the invention relates to compounds that are quinazoline derivatives, methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful in the treatment of diseases or conditions associated with a dysregulation of LPA receptors, in particular fibrosis.
IPC 8 full level
A61P 1/16 (2006.01); A61K 31/517 (2006.01); A61P 9/00 (2006.01); A61P 11/00 (2006.01); A61P 27/02 (2006.01); C07D 401/12 (2006.01); C07D 407/14 (2006.01); C07D 409/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01)
CPC (source: EP US)
A61P 1/16 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 27/02 (2017.12 - EP); C07D 239/94 (2013.01 - US); C07D 401/12 (2013.01 - EP); C07D 407/14 (2013.01 - EP); C07D 409/12 (2013.01 - US); C07D 409/14 (2013.01 - EP); C07D 413/12 (2013.01 - US); C07D 413/14 (2013.01 - EP US); C07D 417/12 (2013.01 - US); C07D 417/14 (2013.01 - EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
MA MD TN
DOCDB simple family (publication)
WO 2021116260 A1 20210617; CA 3157600 A1 20210617; CN 114786771 A 20220722; EP 4072670 A1 20221019; EP 4072670 B1 20231122; EP 4072670 C0 20231122; JP 2023505704 A 20230210; US 2023063121 A1 20230302
DOCDB simple family (application)
EP 2020085460 W 20201210; CA 3157600 A 20201210; CN 202080085862 A 20201210; EP 20820186 A 20201210; JP 2022535580 A 20201210; US 202017784557 A 20201210